Andrew D. Ashe's most recent trade in Verve Therapeutics Inc was a trade of 9,000 Restricted Stock Units done . Disclosure was reported to the exchange on April 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 9,000 | 27,000 | - | - | Restricted Stock Units | |
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 9,000 | 351,509 | - | - | Common Stock | |
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Sale of securities on an exchange or to another person at price $ 4.15 per share. | 01 Apr 2025 | 2,681 | 348,828 | - | 4.1 | 11,126 | Common Stock |
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2025 | 225,000 | 225,000 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2025 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Purchase of securities on an exchange or from another person at price $ 6.26 per share. | 14 May 2024 | 76,000 | 342,509 | - | 6.3 | 475,760 | Common Stock |
| Verve Therapeutics Inc | Ashe Andrew D. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Ashe D. Andrew | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 36,000 | 36,000 | - | - | Restricted Stock Units | |
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 182,800 | 182,800 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 25 Aug 2022 | 51,203 | 221,925 | - | 1.4 | 71,172 | Common Stock |
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2022 | 51,203 | 0 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.48 per share. | 25 Aug 2022 | 33,749 | 255,674 | - | 1.5 | 49,949 | Common Stock |
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2022 | 33,749 | 26,999 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.87 per share. | 25 Aug 2022 | 10,835 | 266,509 | - | 2.9 | 31,096 | Common Stock |
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2022 | 10,835 | 153,278 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Purchase of securities on an exchange or from another person at price $ 32.10 per share. | 02 Dec 2021 | 4,000 | 170,722 | - | 32.1 | 128,420 | Common Stock |
| Verve Therapeutics Inc | Andrew D. Ashe | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 21,599 | 21,599 | - | - | Stock Option (right to buy) |